EUVIMEDEUVIMED entdecken
Crossref

Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS

Heba Aref, Sherin Hammad, Khaled M Darwish iD, Mohamed S Elgawish iD

Chemical Research in Toxicology · 2024

DOI: 10.1021/acs.chemrestox.4c00038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Heba Aref und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt. Hauptthemen laut MEDLINE: Linagliptin, Pioglitazone, Tandem Mass Spectrometry, Drug Interactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The linagliptin (LIN) and pioglitazone HCl (PIO) combination, currently undergoing phase III clinical trials for diabetes mellitus treatment, demonstrated significant improvements in glycemic control. However, the absence of an analytical method for simultaneous determination in biological fluids highlights a crucial gap. This underscores the pressing need for sensitive bioanalytical methods, emphasizing the paramount importance of developing such tools to advance diabetes management strategies and enhance patient care. Herein, a sensitive reverse-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry method was developed for simultaneous determination of LIN and PIO in rat plasma using alogliptin as an internal standard. Chromatographic separation was performed on an Agilent Eclipse Plus C18 (4.6 × 100 mm, 3.5 μm) using an isocratic mobile phase system consisting of ammonium formate (pH 4.5) and methanol using an acetonitrile-induced protein precipitation technique for sample preparation. Multiple reaction monitoring in positive ion mode was used for quantitation of the precursor to production at m/z 473.2 → 419.9 for LIN, 357.1 → 134.2 for PIO, and 340.3 → 116.1 for ALO. The linearity range was 0.5 to 100 and 1 to 2000 ng/mL for LIN and PIO, respectively. The developed method was validated as per US-FDA guidelines and successfully applied to clinical pharmacokinetic and drug-drug interaction studies with a single oral administration of LIN and PIO in rat plasma. Pharmacokinetic parameters of LIN were significantly influenced by the concomitant administration of PIO and vice versa. Molecular modeling revealed the significant interaction of LIN and PIO with P-glycoprotein. Therefore, the drug-drug interaction between LIN and PIO deserves further study to improve drug therapy and prevent dangerous adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinagliptinPioglitazoneTandem Mass SpectrometryDrug InteractionsRats, Sprague-DawleyAnimalsRatsMaleChromatography, High Pressure LiquidMolecular StructureHypoglycemic AgentsLiquid Chromatography-Mass Spectrometry

Substanzen

LinagliptinPioglitazoneHypoglycemic Agents

Autor:innen und Institutionen

  • Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
  • Medicinal Chemistry Department, Faculty of Pharmacy, El Menoufia University, El Menoufia, Shebin El Kom 32511, Egypt.
  • Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta 31511, Egypt.
  • Chemistry Department, Korea University, Seoul 02841, Korea Republic.

ORCID-Profile: Khaled M Darwish, Mohamed S Elgawish

Zitieren

APA

Aref, H., Hammad, S., Darwish, K. M., & Elgawish, M. S. (2024). Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00038

Vancouver

Aref H, Hammad S, Darwish KM, Elgawish MS. Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.4c00038

BibTeX
@article{Aref2024,
  author = {Aref, Heba and Hammad, Sherin and Darwish, Khaled M and Elgawish, Mohamed S},
  title = {Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS},
  journal = {Chemical Research in Toxicology},
  year = {2024},
  doi = {10.1021/acs.chemrestox.4c00038}
}
Kostenlos starten →